Incremental cost-effectiveness of exercise echocardiography vs. SPECT imaging for the evaluation of stable chest pain

European Heart Journal

Volumn 27, Issue 20, 2006, Pages 2448-2458

  Shaw, Leslee J ^a   Marwick, Thomas H ^b   Berman, Daniel S ^a   Sawada, Stephen ^c   Heller, Gary V ^d   Vasey, Charles ^e   Miller, D Douglas ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARTFORD HOSPITAL   (United States)

^e Asheville Cardiology Associates   (United States)

^f SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cost effectiveness; Echocardiography; Prognosis; SPECT; Stable angina

Indexed keywords

ADULT; AGED; ARTICLE; CHI SQUARE TEST; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; EXERCISE; EXERCISE ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE WALL MOTION; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MONEY; PATIENT REFERRAL; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RESOURCE ALLOCATION; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX PAIN; UNITED STATES;

AGED; ANALYSIS OF VARIANCE; ANGINA PECTORIS; COST-BENEFIT ANALYSIS; DEATH, SUDDEN, CARDIAC; DISEASE-FREE SURVIVAL; ECHOCARDIOGRAPHY, STRESS; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33749496245     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehl204     Document Type: Article

References (59)

1. Garber AM, Solomon NA. Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease. Ann Intern Med 1999;130:719-728.
2. Kuntz KM, Fleischmann KE, Hunink MG, Douglas PS. Cost-effectiveness of diagnostic strategies for patients with chest pain. Ann Intern Med 1999;130:709-718.
3. Mowatt G, Vale L, Brazzelli M, Hernandez R, Murray A, Scott N, Fraser C, McKenzie L, Gemmell H, Hillis G, Metcalfe M. Systematic review of the effectiveness and cost-effectiveness, and economic evaluation of myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction. Health Technol Assess 2004;8:1-207. iii-iv.
4. Underwood SR, Anagnostopoulos C, Cerqueira M, Ell PJ, Flint EJ, Harbinson M, Kelion AD, Al-Mohammad A, Prvulovich EM, Shaw LJ, Tweddel AC, British Cardiac Society; British Nuclear Cardiology Society; British Nuclear Medicine Society; Royal College of Physicians of London; Royal College of Radiologists. Myocardial perfusion scintigraphy: the evidence. Eur J Nucl Med Mol Imaging 2004;31:261-291.
5. Kim C, Kwok YS, Saha S, Redberg RF. Diagnosis of suspected coronary artery disease in women: a cost-effectiveness analysis. Am Heart J 1999;137:1019-1027.
6. Marwick TH, Case C, Vasey C, Allen S, Short L, Thomas JD. Prediction of mortality by exercise echocardiography: a strategy for combination with the Duke treadmill score. Circulation 2001;103:2566-2571.
7. Arruda-Olson AM, Juracan EM, Mahoney DW, McCully RB, Roger VL, Pellikka PA. Prognostic value of exercise echocardiography in 5798 patients: is there a gender difference? J Am Coll Cardiol 2002;39:625-631.
8. Elhendy A, Arruda AM, Mahoney DW, Pellikka PA. Prognostic stratification of diabetic patients by exercise echocardiography. J Am Coll Cardiol 2001;37:1551-1557.
9. Elhendy A, Shub C, McCully RB, Mahoney DW, Burger KN, Pellikka PA. Exercise echocardiography for the prognostic stratification of patients with low pretest probability of coronary artery disease. Am J Med 2001;111:18-23.
10. Bigi R, Desideri A, Cortigiani L, Bax JJ, Celegon L, Fiorentini C. Stress echocardiography for risk stratification of diabetic patients with known or suspected coronary artery disease. Diab Care 2001;24:1596-1601.
11. Davar JL, Roberts EB, Coghlan JG, Evans TR, Lipkin DP. Prognostic value of stress echocardiography in women with high (≥80%) probability of coronary artery disease. Postgrad Med 2001;77:573-577.
12. Arruda-Olson AM, McCully RB, Oh JK, Mahoney DW, Seward JB, Pellikka PA. Prognostic value of exercise echocardiography in patients after coronary artery bypass surgery. Am J Cardiol 2001;87:1069-1073.
13. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, Friedman J, Diamond GA. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97:535-543.
14. Shaw LJ, Hachamovitch R, Heller GV, Marwick TH, Travin MI, Iskandrian AE, Kesler K, Travin MI, Lewin HC, Hendel RC, Borges-Neto S, Miller DD. Noninvasive strategies for the estimation of cardiac risk in stable chest pain patients. The Economics of Noninvasive Diagnosis (END) Study Group. Am J Cardiol 2000;86:1-7.
15. Hachamovitch R, Berman DS, Kiat H, Cohen I, Friedman JD, Shaw LJ. Value of stress myocardial perfusion single photon emission computed tomography in patients with normal resting electrocardiograms: an evaluation of incremental prognostic value and cost-effectiveness. Circulation 2002;105:823-829.
16. Giri S, Shaw LJ, Murthy DR, Travin MI, Miller DD, Hachamovitch R, Kesler KL, Borges-Neto S, Berman DS, Waters DD, Heller GV. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002;105:32-40.
17. Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM, Grunwald MA, Levy D, Lytle BW, O'Rourke RA, Schafer WP, Williams SV, Ritchie JL, Cheitlin MD, Eagle KA, Gardner TJ, Garson A Jr, Russell RO, Ryan TJ, Smith SC Jr. ACC/AHA/ACP-ASIM practice guidelines for management of patients with chronic stable angina. J Am Coll Cardiol 1999;33:2092-2197.
18. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC;. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Committee to Update the 1997 Exercise Testing Guidelines. ACC/AHA 2002 Guideline Update for Exercise Testing. Circulation 2002;106:1883-1892.
19. Shaw LJ, Peterson ED, Kesler KL, DeLong ER, DeLong ER, Harrell FE Jr, Shaw LK, Muhlbaier LH, Mark DB. Use of a prognostic treadmill score in identifying diagnostic coronary disease subgroups and altering patient management. Circulation 1998;98:1622-1630.
20. Feigenbaum H. Exercise echocardiography. J Am Soc Echo 1988;1:161-166.
21. Foster E, Cahalan MK. The search for intelligent quantitation in echocardiography: 'eyeball,' 'trackball' and beyond. J Am Coll Cardiol 1993;22:848-850.
22. Hoffmann R, Lethen H, Marwick T, Rambaldi R, Fioretti P, Pingitore A, Picano E, Buck T, Erbel R, Flachskampf FA, Hanrath P. Standardized guidelines for the interpretation of dobutamine echocardiography reduce interinstitutional variance in interpretation. Am J Cardiol 1998;82:1520-1524.
23. Bach DS, Muller DW, Gros BJ, Armstrong WF. False positive dobutamine stress echocardiograms: characterization of clinical, echocardiographic and angiographic findings. J Am Coll Cardiol 1994;24:928-933.
24. Shaw LJ, Hachamovitch R, Heller GV, Marwick TH, Travin MI, Iskandrian AE, Kesler K, Travin MI, Lewin HC, Hendel RC, Borges-Neto S, Miller DD. The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter Study Group. J Am Coll Cardiol 1999;33:661-669.
25. Pryor DB, Shaw L, McCants CB, Lee KL, Mark DB, Harrell FE Jr, Muhlbaier LH, Califf RM. Value of the history and physical in identifying patients at increased risk for coronary artery disease. Ann Intern Med 1993;118:81-90.
26. www.cdc.gov/nchs/fastats/lifeexpec.htm (August 2002)
27. Marwick TH, Shaw LJ, Case C, Vasey C, Thomas JD. Selection of initial investigation for risk evaluation in coronary artery disease: cost and effectiveness implications of exercise ECG and exercise echocardiography. Eur Heart J 2003;24:1153-1163.
28. http://www.hcfa.gov/stats/pu.les.htm (15 July 2003)
29. Gold M. Cost-effectiveness in health and medicine. New York, NY: Oxford University Press; 1996.
30. Office of Technology Assessment. The implications of cost-effectiveness analysis of medical technology. Washington, DC: U.S. Government Printing Office; 1980 (Chapters 1-4).
31. Doubilet P, Weinstein MC, McNeil BJ. Use and misuse of the term 'cost effective' in medicine. N Engl J Med 1986;314:253-256.
32. Garber AM, Phelps CE. Economic foundations of cost-effectiveness analysis. Health Econ 1997;16:1-31.
33. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 1996;276:1253-1258.
34. Petitti DB. Meta-analysis, decision analysis, and cost-effectiveness analysis: methods for quantitative synthesis in medicine. New York, NY: Oxford University Press; 1994.
35. Shaw LJ, Eisenstein EL, Hachamovitch R, Heller GV, Miller DD; for the Economics of Noninvasive Diagnosis Multicenter. A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: Part II. J Nucl Cardiol 1997;4:52-60.
36. Mushlin AI, Ruchlin HS, Callahan MA. Cost effectiveness of diagnostic tests. Lancet 2001;358:1353-1355.
37. Shaw LJ, Mulvagh SL, Jacobson C, Denham C. Cost implications of diagnosing coronary disease. Eur Heart J 2000;21:477-482.
38. Kuntz KM, Fleischmann KE, Hunink MG, Douglas PS. Cost-effectiveness of diagnostic strategies for patients with chest pain. Ann Intern Med 1999;130:709-718.
39. Weintraub WS, Mahoney EM, Ghazzal ZM, King SB III, Culler SD, Morris DC, Douglas JS Jr. Trends in outcome and costs of coronary intervention in the 1990s. Am J Cardiol 2001;88:497-503.
40. Cohen DJ, Becker ER, Culler SD, Ellis S, Green LM, Schnitzler RN, Simon AW, Weintraub WS. Impact of patient characteristics, complications, and facility volume on the costs and time of cardiac catheterization and coronary angioplasty in 70 catheterization laboratories. Am J Cardiol 2000;86:595-601.
41. Weintraub WS, Maildin PD, Becker E, Kosinski AS, King SB. A comparison of the costs of and quality of life after coronary angioplasty or coronary surgery for multivessel CAD. Results from the Emory Angioplasty Surgery Trial (EAST). Circulation 1995;92:2831-2840.
42. Russell MW, Huse DM, Drowns S, Haul EC, Hartz SC. Direct medical costs of coronary artery disease in the United States. Am J Cardiol 1998;81:1110-1115.
43. Underwood SR, Godman B, Salyani S, Ogle JR, Ell PJ. Economics of myocardial perfusion imaging in Europe - The EMPIRE Study. Eur Heart J 1999;20:157-166.
44. Berry E, Kelly S, Hutton J, Harris KM, Roderick P, Boyce JC, Cullingworth J, Gathercole L, O'Connor PJ, Smith MA. A systematic literature review of spiral and electron beam computed tomography: with particular reference to clinical applications in hepatic lesions, pulmonary embolus and coronary artery disease. Health Tech Assess 1999;3:1-121.
45. Rumberger JA, Behrenbeck T, Breen JF, Sheedy PF. Coronary calcification by electron beam computed tomography and obstructive coronary artery disease: a model for costs and effectiveness of diagnosis as compared with conventional cardiac testing methods. J Am Coll Cardiol 1999;33:453-462.
46. http://www.americanheart.org/statistics/economic.html (30 August 2003).
47. Kim C, Kwok YS, Saha S, Redberg R. Diagnosis of suspected coronary artery disease in women: a cost-effectiveness analysis. Am Heart J 1999;137:1019-1027.
48. Laufer E, Wahi S, Lim YL. Cost-effectiveness and accuracy of exercise stress echocardiography in the non-invasive diagnosis of coronary heart disease. Aust NZ J Med 2000;30:660-667.
49. www.aihw.gov.au/publications/health/hsccdda93-4 (August 2002).
50. www.hta.nhsweb.nhs.uk (August 2002).
51. Mark DB, Shaw LJ, Lauer MS, O'Malley PG, Heidenreich P. Bethesda Conference No. 34-Task Force 5: is atherosclerosis imaging cost effective? J Am Coll Cardiol 2003;41:1906-1917.
52. Patterson RE, Eisner RL, Horowitz SF. Comparison of cost-effectiveness and utility of exercise ECG, single photon emission computed tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease. Circulation 1995;91:54-65.
53. Marwick TH, Anderson T, Williams MJ, Haluska B, Melin JA, Pashkow F, Stewart WJ, Thomas JD. Exercise echocardiography is an accurate and cost-efficient technique for the detection of coronary artery disease in women. J Am Coll Cardiol 1995;26:335-341.
54. Shaw LJ, Culler SD, Becker NR. Current evidence on cost effectiveness of non-invasive cardiac testing. Subsection E. Analytic Approaches to Cost Effectiveness and Outcomes Measurement in Cardiovascular Imaging. In: Pohost G, O'Rourke R, Shah P, D Berman eds. Imaging in Cardiovascular Disease. Philadelphia, PA: Lippincott, Williams & Wilkins; 2000. p479-500.
55. Levin DC, Parker L, Intenzo CM, Sunshine JH. Recent rapid increase in utilization of radionuclide myocardial perfusion imaging and related procedures: 1996-1998 practice patterns. Radiology 2002;222:144-148.
56. http://www.acc.org/advocacy/advoc_issues/impactchart.htm (August 2002).
57. Kwok Y, Kim C, Grady D, Segal M, Redberg R. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 1999;83:660-666.
58. Fleischmann KE, Hunink MG, Kuntz KM, Douglas PS. Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance. JAMA 1998;280:913-920.
59. Goldman L, Garber AM, Grover SA, Hlatky MA. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for CAD events. Task Force 6. Cost effectiveness of assessment and management of risk factors. J Am Coll Cardiol 1996;27:1020-1030.